Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
LCTX
$0.94
+1.13%
LCTX
· Lineage Cell Therapeutics, Inc.
$0.94
+0.01 (+1.13%)
At close · Oct 6
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$260.49M
Shares
252.91M
Volume · Oct 6
967.63K
Avg daily vol (3M)
1.14M
All webcasts
Earnings call · FY2024 Q4
Lineage Cell Therapeutics, Inc. (LCTX) Q4 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$2.87M
+37.4% YoY
Net income · derived Q4
-$3.27M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 10, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 10, 2025 · complete as-filed document